Reporting owner · CIK 0001310204

Dickinson Andrew D

Visual SEC Form 4 history across 1 companies, 24 transactions and 7 filings.

CFOChief Financial OfficerGILEAD SCIENCES, INC.
Open-market mix
Latest filingAug 18, 2026, 11:06 PM
Filings7Form 4 records
Buying$00 purchases
Selling$28.8M5 sales
Net value−$28.8MBuys minus sells
Companies12 securities
Most recentAug 17, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-52Jan 252Feb 25Feb 261Aug 26

Net value flow

Buys minus sells

Jan 25
−$14.1M
Feb 25
−$14.3M
Feb 26
$0
Aug 26
−$415.1K

Transaction texture

Ownership and ticket size

Average P/S size$5.8M
Median P/S size$415.1K
Direct24
Indirect0
Aug 17, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern1Derivative Transactionfiling-context7Direct Ownershipfiling-context24Large Holdings Increaseholdings3Large Holdings Reductionholdings6Large Salesize2Repeat Sellerpattern310b5-1 Detectedfiling-context19

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at GILEAD SCIENCES, INC. on Aug 17, 2026 valued at $415,080.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at GILEAD SCIENCES, INC. on Aug 17, 2026 valued at $415,080.

Review SEC filing

Associated companies

Visual map of known reporting history

GILDGILEAD SCIENCES, INC.24 transactions · latest Aug 18, 2026, 11:06 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
GILDDickinson Andrew D
CFO
sale10b5-13.00k-$41.5MS
Cluster Selling Direct Ownership 10b5-1 Detected
+4.5%08/1808/17
GILDDickinson Andrew D
CFO
withholding24.8k-$355MF
Direct Ownership
−8.8%02/0502/03
GILDDickinson Andrew D
CFO
grant44.8k$0A
Direct Ownership
−8.8%02/0502/03
GILDDickinson Andrew D
CFO
sale10b5-12.50k-$26.0MS
Direct Ownership Repeat Seller 10b5-1 Detected
—02/19/202502/18/2025
GILDDickinson Andrew D
CFO
exercise10b5-118.2k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
—02/14/202502/12/2025
GILDDickinson Andrew D
CFO
exercise10b5-115.6k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
—02/14/202502/12/2025
GILDDickinson Andrew D
CFO
exercise10b5-126.1k$0M
Derivative Transaction Direct Ownership Large Holdings Reduction+1
—02/14/202502/12/2025
GILDDickinson Andrew D
CFO
exercise10b5-177.6k$0M
Derivative Transaction Direct Ownership Large Holdings Reduction+1
—02/14/202502/12/2025
GILDDickinson Andrew D
CFO
sale10b5-1137k-$1.40BS
Direct Ownership Large Holdings Reduction Large Sale+2
—02/14/202502/12/2025
GILDDickinson Andrew D
CFO
exercise10b5-118.2k$152MM
Direct Ownership 10b5-1 Detected
—02/14/202502/12/2025

Dickinson Andrew D Insider Activity FAQ

SEC Form 4 context

Who is Dickinson Andrew D?

Dickinson Andrew D is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001310204.

Which companies has Dickinson Andrew D reported transactions for?

GILEAD SCIENCES, INC.

When was Dickinson Andrew D's latest insider buy?

No open-market insider purchase is available for this period.

When was Dickinson Andrew D's latest insider sale?

sale at GILEAD SCIENCES, INC. on Aug 17, 2026 valued at $415,080.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.